- Ainos (NASDAQ:AIMD) introduces AI Nose technology at COMPUTEX 2025, collaborating with Japan's robotics leader ugo.
- AI Nose achieves 99% accuracy and aims to transform healthcare, robotics, and industrial safety.
- The electronic nose market is projected to reach $76.5 billion by 2032.
Ainos, Inc. (NASDAQ:AIMD) has unveiled its revolutionary AI Nose technology at COMPUTEX 2025, presented in collaboration with ugo, Japan's premier service robotics firm. This strategic showcase marks the first public demonstration of AI-driven scent digitization, poised to redefine various sectors including healthcare, robotics, smart manufacturing, and industrial safety.
The AI Nose platform employs MEMS gas sensor arrays and machine learning to convert scents into digital identifiers known as Smell IDs. This technology boasts a 99% accuracy in model development, while achieving approximately 90% accuracy in healthcare applications and 80% in semiconductor environments. The initiative highlights a progressive leap in robotic olfaction, opening new frontiers in machine perception beyond traditional sensory capabilities.
The market for electronic noses is on a robust growth trajectory, with forecasts suggesting an expansion to $76.5 billion by 2032. This projected growth is fueled by burgeoning demand in sectors such as robotics, industrial monitoring, healthcare, and environmental sensing.
At the themed "AI Next" COMPUTEX 2025 event, Booth InnoVEX S0324 at the Taipei Nangang Exhibition Center serves as the venue for showcasing AI-powered scent digitization applications aimed at enhancing smart infrastructure, elder care, and ensuring industrial safety. Chun-Hsien (Eddy) Tsai, CEO of Ainos, emphasized the transformative potential of empowering machines with the ability to smell, heralding a new category in machine intelligence.
